Creon (pancrelipase) Delayed-Release Capsules Dose By Lipase Units Lipase 36,000 USP Units Rx only NDC 0032-3016-13 100 Capsules Marketed by: AbbVie Inc. North Chicago, IL 60064, U.S.A.

Recall Number: D-0402-2021

Firm: Cardinal Health Inc.

Classification: Class II

Status: Terminated

Report Date: 20210602

Initiation Date: 20210315

Termination Date: 20240617

Reason for Recall

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Product Description

Creon (pancrelipase) Delayed-Release Capsules Dose By Lipase Units Lipase 36,000 USP Units Rx only NDC 0032-3016-13 100 Capsules Marketed by: AbbVie Inc. North Chicago, IL 60064, U.S.A.

DrugLabelsHub provides FDA drug labeling information for reference only. Always consult a healthcare professional.

Data source: openFDA · Updated regularly